(Q53440843)

14 May 2018

title

Rifampin enhances the glucose-lowering effect of metformin and increases OCT1 mRNA levels in healthy participants. (English)

1 reference

14 May 2018

1 reference

1 reference

S K Cho

1

1 reference

14 May 2018

J S Yoon

2

1 reference

14 May 2018

M G Lee

3

1 reference

14 May 2018

D H Lee

4

1 reference

14 May 2018

L A Lim

5

1 reference

14 May 2018

K Park

6

1 reference

14 May 2018

M S Park

7

1 reference

14 May 2018

J-Y Chung

8

1 reference

14 May 2018

language of work or name

English

0 references

publication date

26 January 2011

1 reference

14 May 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

14 May 2018

volume

89

1 reference

14 May 2018

issue

3

1 reference

14 May 2018

page(s)

416-421

1 reference

14 May 2018

Mechanism by which metformin reduces glucose production in type 2 diabetes

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

Measurement of the renal clearance of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

Cloning and characterization of two human polyspecific organic cation transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

Resolution of insulin-requiring diabetes after cessation of chemotherapy for tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

Identification and functional characterization of genetic variants of human organic cation transporters in a Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

Genetic variants of the organic cation transporter 2 influence the disposition of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

Metformin transport by renal basolateral organic cation transporter hOCT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

Clinical pharmacokinetics of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: comparison between human segments and Caco-2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

Nitric oxide down-regulates the expression of organic cation transporters (OCT) 1 and 2 in rat kidney during endotoxemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

Tissue distribution, ontogeny and induction of the transporters Multidrug and toxin extrusion (MATE) 1 and MATE2 mRNA expression levels in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

PXR and CAR in energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

Cloning and functional expression of a human liver organic cation transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

7 January 2021

Genetic variants of organic cation transporter 2 (OCT2) significantly reduce metformin uptake in oocytes

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

7 January 2021

Interaction of rifampin and glyburide

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

7 January 2021

Effect of pregnane X receptor ligand on pharmacokinetics of substrates of organic cation transporter Oct1 in rats

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

7 January 2021

Interaction of gliclazide and rifampicin

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

7 January 2021

Localization of organic cation transporters OCT1 and OCT2 in rat kidney

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.266

7 January 2021

Identifiers

DOI

10.1038/CLPT.2010.266

1 reference

14 May 2018

1 reference

14 May 2018